Clin2
NCT07279194Likely a fitRecruiting

Study of HDM1005 for weight loss in Chinese adults without diabetes

Obesity & Overweight

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial tests a new medication, HDM1005, to help people with obesity or overweight who do not have diabetes lose weight. It is for Chinese adults who have a high body mass index (BMI) or a BMI above 24 with weight-related health problems like high blood pressure or fatty liver.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
825 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • Your BMI is 28 or higher, or 24 or higher with a weight-related health condition (like high blood pressure or fatty liver)
  • You have not had diabetes (type 1 or type 2)
  • Your weight has stayed steady (not changed by more than 5%) in the last 3 months
  • You have not taken certain weight-loss or diabetes medications in the last 3 months
  • You are willing to use contraception if needed and follow the study plan

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07521631Recruiting· Phase 2
HDM1005 versus Tirzepatide for weight management in obese adults

This study tests whether a new injectable medication called HDM1005 works as well as tirzepatide (a GLP-1 drug) for weight loss in adults with obesity but no diabetes. Both medications work similarly in the body to help control appetite and weight.

Shanghai
NCT06885021Not yet recruiting· Phase 3
A tablet to help Chinese adults with overweight and obesity lose weight

This study tests a new oral medication (tablet) called HDM1002 to help people who are overweight or obese lose weight and keep it off. The medication is designed to regulate appetite and digestion, and the trial will check how safe and effective it is for Chinese adults.

NCT06886126Recruiting· Phase 2
Testing HDM1005 injection for weight loss in adults with obesity

This study tests an experimental injection called HDM1005 for adults with obesity who do not have diabetes. The goal is to see if it helps with weight loss when combined with diet and exercise.

Nanjing
NCT07394114Recruiting· Phase 3
Study of a new medicine for type 2 diabetes not controlled by diet and exercise

This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.

Beijing
NCT07110766Not yet recruiting· Phase 1
Study of MDR-001 for weight loss in people with obesity or overweight

This study tests an experimental drug called MDR-001 to see if it can help people with obesity or overweight lose weight. It may be an option for you if you have weight-related health issues like high blood sugar, high blood pressure, or fatty liver.

Ch’ang-ch’un, Jilin
NCT07845513Not yet recruiting· Phase 1
Study of a new weight-loss medicine in Chinese adults

This study tests a new medicine (PF-08653944) for weight loss in Chinese adults who are overweight or have obesity. It aims to see if the medicine is safe and how it works in the body.

Beijing, Beijing Municipality

Hear when a new Obesity & Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.